In contrast to many tumor types, HIF1α and HIF2α have opposite roles in ccRCC biology, where HIF1α acts as a tumor suppressor and HIF2α acts as an oncogene [4]. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.